danforthimage3.jpg

News

BioSTL Press Releases

Israeli Agtech Company Chooses St. Louis as U.S. Headquarters

on November 24, 2014
by BioSTL

ST. LOUIS – November 24, 2014 – BioSTL, the St. Louis organization advancing regional prosperity by cultivating the innovation ecosystem and bioscience sector, announced that Israeli agtech company Kaiima Bio-Agritech has selected St. Louis as the location of its U.S. headquarters. Kaiima’s decision represents the first success of BioSTL’s newly-launched initiative targeting Israeli companies for recruitment.


Read the full news release

BioGenerator Invest in Prostate Management Diagnostics Inc.

on November 7, 2014
by BioGenerator

ST. LOUIS – November 7, 2014 – BioGenerator, an investment and entrepreneur support organization, has invested pre-seed funds into a new, innovative company, Prostate Management Diagnostics Inc. (PMDI).  


Read the full news release

BioSTL Launches International Innovation Connection

on October 17, 2014
by BioSTL

ST. LOUIS – October 17, 2014 – BioSTL, the St. Louis organization advancing regional prosperity by cultivating the innovation ecosystem and bioscience sector, announced the launch of a new initiative, the St. Louis-Israel Innovation Connection (SLIIC). SLIIC is building a direct link between St. Louis and the State of Israel with the aim of recruiting Israeli companies that are seeking to establish a United States presence and that are aligned with St. Louis’ business, scientific and technological strengths.


Read the full news release

BioGenerator Portfolio Company Finds Success in St. Louis

on October 3, 2014
by BioGenerator

ST. LOUIS – October 3, 2014—BioGenerator congratulates its portfolio company, Adarza BioSystems, on closing a $6.8 million Series A financing round and its plans to expand its St. Louis presence.


Read the full news release

Monsanto’s $2.5 Million Commitment Expands BioSTL Effort to Grow St. Louis’ Prosperity through Bioscience

on March 27, 2014
by BioSTL

ST. LOUIS (March 27, 2014) — BioSTL announced today a five-year, $2.5 million grant from the Monsanto Company that will support the nonprofit’s work to promote regional economic growth and advance St. Louis’ standing as a leader in bioscience.  Funding from Monsanto will allow BioSTL to step up its collaborative efforts to build a strong bioscience ecosystem that capitalizes on St. Louis’ world-class plant and medical science strengths. The announcement came during InvestMidwest 2014, a venture capital conference that showcases 40-45 companies from throughout the Midwest in the three industry tracks of life sciences, technology, and food/ag/bioenergy.


Read the full news release

BioSTL Receives Grant to Promote Inclusion of Women & Minorities in Bioscience and Entrepreneurship

on February 7, 2014
by BioSTL

ST. LOUIS (February 7, 2014) — BioSTL announced today the receipt of a $100,000 grant from the Blackstone Charitable Foundation to catalyze a new pilot programming phase of the St. Louis Bioscience Inclusion Initiative. The goal of this new programming is to strengthen the region’s bioscience ecosystem by identifying high-potential women and minority bioscience entrepreneurs and providing a systematic pathway for them to create viable high-growth ventures.


Read the full news release

St. Louis’ BioGenerator Named among Best Practices in the Western Hemisphere

on December 12, 2013
by BioSTL & BioGenerator

ST. LOUIS (December 12, 2013) — The BioGenerator has been recognized as a Center of Best Practice in the second annual “Signs of Competitiveness in the America’s” report from the Inter-American Competitiveness Network under the auspices of the Technical Secretariat of the Organization of American States.


Read the full news release

World Series tied 2-2, Biocluster CEOs Make Their Bets

on October 28, 2013
by BioSTL & MassBio

With the World Series tied 2-2 and the teams gearing up for a big game at Busch Stadium tonight, the leaders of St. Louis’ and Boston’s biotech clusters have decided to raise the stakes with a friendly wager.


Read the full news release

BioGenerator Wins National Award of Excellence for Advancing Regional Competitiveness

on September 16, 2013
by BioGenerator

ST. LOUIS (September 16, 2013) — BioGenerator was named a winner of SSTI’s 2013 “Excellence in TBED” (technology-based economic development) award, recognizing BioGenerator and its programs as national models for investing in science, technology and innovation to grow the economy and create high-paying jobs. SSTI is a national nonprofit organization that leads, supports and strengthens efforts to improve state and regional economies through science, technology, and innovation.


Read the full news release

BioGenerator Adds 4 Industry Experts to Entrepreneur In Residence Program

on August 6, 2013
by BioGenerator

ST. LOUIS (August 5, 2013) — Four additional Entrepreneurs In Residence (EIRs) have joined the BioGenerator, bringing the organization’s roster of EIRs to 12 – up from five last summer. The EIRs will support the creation and growth of new bioscience companies in the St. Louis region.


Read the full news release

June 18-19: SBIR/STTR Seminar on NIH Proposal Prep

on May 25, 2013
by BioSTL

DID YOU KNOW?       The chances of receiving a SBIR grant are 18x greater than getting VC funding

18% of NIH SBIR applications will be funded
Midsize VC Funds see 400-600 business plans annually, investing in only 3-4
A less than 1% chance of funding


Read the full news release

BioGenerator Investment Helps Adarza BioSystems Establish Operations in St. Louis

on April 17, 2013
by BioGenerator

ST. LOUIS (April 17, 2013) — BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business and product development in St. Louis as well as its manufacturing activities.


Read the full news release

BioGenerator Invests in Antegrin Therapeutics

on April 2, 2013
by BioSTL & BioGenerator

ST. LOUIS (April 2, 2013) — BioGenerator – the non-profit venture development organization of BioSTL – recently closed on an investment in Antegrin Therapeutics through its i6 Project Fund. The investment will allow Antegrin to select and advance lead compounds for the treatment of human fibrotic diseases, initially targeting idiopathic pulmonary fibrosis (IPF), a progressive life-threatening condition. IPF has very high mortality without lung transplant, and there are currently no FDA-approved drug treatments.


Read the full news release

Monsanto Supports BioGenerator Through Loaned Executive

on February 26, 2013
by BioGenerator

ST. LOUIS (February 26, 2013) — James McCarter, M.D., Ph.D. is joining the BioGenerator as a Senior Entrepreneur in Residence (EIR). Jim currently serves as an Entrepreneur in Residence with Monsanto Company. Monsanto is partnering with the BioGenerator, the non-profit venture development organization of BioSTL, to support the development of new startups in St. Louis by lending a portion of Jim’s time to this effort.


Read the full news release

BioGenerator Investment Helps Relocate Tansna Therapeutics to St. Louis

on February 19, 2013
by BioGenerator

ST. LOUIS (February 19, 2013) — BioGenerator – the non-profit venture development organization of BioSTL – recently closed on a Spark Fund investment in Tansna Therapeutics, Inc., to support further commercialization of the company’s epilepsy drugs and to relocate the company to St. Louis from Iowa. Tansna’s development has also been supported by Alan MacInnes, an Entrepreneur-in-Residence (EIR) with the BioGenerator. The company will locate in the BioGenerator’s Accelerator Labs facility at CORTEX.


Read the full news release

BioGenerator Adds Additional Industry Expert to Entrepreneur-in-Residence Program

on February 7, 2013
by BioGenerator

ST. LOUIS (February 7, 2013) — Dr. Cheryl Watkins-Moore has joined as an Entrepreneur-in-Residence (EIR) with the BioGenerator – the non-profit venture development organization of BioSTL – to create, lead, and support new bioscience companies in St. Louis.


Read the full news release

February 13-14: SBIR/STTR Seminar on NIH Proposal Prep

on January 16, 2013
by BioSTL

DID YOU KNOW?       The chances of receiving a SBIR grant are 18x greater than getting VC funding

18% of NIH SBIR applications will be funded
Midsize VC Funds see 400-600 business plans annually, investing in only 3-4
A less than 1% chance of funding

 


Read the full news release

October 2-3: SBIR/STTR 101: Proposal Prep - NIH Focus

on September 1, 2012
by BioSTL

BioSTL is sponsoring an intensive, two-day seminar given by Lisa Kurek, Managing Partner of Biotechnology Business Consultants (BBC), a nationally acknowledged expert in her field.  This seminar is a let's get down to business session that presents a highly organized “How to?” approach for strategizing, conceptualizing, writing, and submitting successful SBIR/STTR applications.


Read the full news release

Veteran Industry & Finance Expert Will Advance St. Louis’ Bioscience Cluster Building Effort

on July 2,2012
by BioSTL

ST. LOUIS (July 2, 2012) — BioSTL announced the addition of Jim Jaacks as Vice President for Finance & Administration to help achieve the mission of promoting economic growth and regional prosperity that capitalizes on St. Louis’ world class medical and plant biosciences.


Read the full news release

Industry Experts Recruited to Grow Bioscience Companies in St. Louis

on June 22, 2012
by BioSTL & BioGenerator

ST. LOUIS (June 22, 2012) — Four new Entrepreneurs In Residence (EIRs) have joined the BioGenerator, a nonprofit subsidiary of BioSTL, to create, lead, and support new bioscience companies St. Louis. The EIRs will work with existing start-up companies across the region to further their growth and with researchers and entrepreneurs to launch new enterprises.


Read the full news release

Regional collaboration wins Bioscience Jobs Accelerator grant

on October 4, 2011
by BioSTL

Several St. Louis area organizations collaborated to win a $1.8 million multi-agency federal grant called the Jobs and Innovation Accelerator Challenge, aimed at advancing high-growth industry clusters through public-private partnerships that foster job creation, global competition and regional economic growth. The St. Louis initiative is one of only 20 selected regions, out of 125 applicants nationwide, and the only one focused on a bioscience cluster.


Read the full news release

$30 Million Commitment to Advance St. Louis Bioscience

on September 27, 2011
by BioSTL

A new regional organization to champion St. Louis bioscience, BioSTL (evolved from the Coalition for Plant and Life Sciences), announced today a $30 million commitment from Washington University in St. Louis, BJC HealthCare, and the St. Louis Life Sciences Project to forward bioscience company creation and drive economic growth in St. Louis.


Read the full news release

BioSTL Welcomes New Communications Manager

on July 22, 2014
by BioSTL

ST. LOUIS – July 22, 2014 – BioSTL today announced the hiring of Colleen Ward as Communications Manager. In this new role, Ward will oversee communications and marketing initiatives for BioSTL and its subsidiary BioGenerator. She will also steward efforts on behalf of the region’s entire bioscience community to raise national and international awareness about St. Louis’ unique convergence of corporate, academic, and entrepreneurial strengths in bioscience.

Read the full news release

Newsletters

See Older News Stories >